Airain ltd reduced its stake in shares of STERIS PLC (NYSE:STE) by 12.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,372 shares of the medical equipment provider’s stock after selling 2,285 shares during the period. Airain ltd’s holdings in STERIS PLC were worth $1,253,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Russell Investments Group Ltd. raised its stake in STERIS PLC by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock worth $9,171,000 after buying an additional 48,188 shares during the period. Oregon Public Employees Retirement Fund raised its stake in STERIS PLC by 1.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 30,160 shares of the medical equipment provider’s stock worth $2,095,000 after buying an additional 400 shares during the period. Canada Pension Plan Investment Board raised its stake in STERIS PLC by 112.8% in the first quarter. Canada Pension Plan Investment Board now owns 38,100 shares of the medical equipment provider’s stock worth $2,646,000 after buying an additional 20,200 shares during the period. Great West Life Assurance Co. Can raised its stake in STERIS PLC by 6.4% in the first quarter. Great West Life Assurance Co. Can now owns 129,784 shares of the medical equipment provider’s stock worth $9,021,000 after buying an additional 7,839 shares during the period. Finally, State Treasurer State of Michigan raised its stake in STERIS PLC by 0.6% in the first quarter. State Treasurer State of Michigan now owns 34,500 shares of the medical equipment provider’s stock worth $2,396,000 after buying an additional 200 shares during the period. 94.65% of the stock is currently owned by institutional investors.

Shares of STERIS PLC (STE) opened at 86.88 on Friday. STERIS PLC has a 12-month low of $63.80 and a 12-month high of $87.49. The company’s 50-day moving average is $84.12 and its 200-day moving average is $76.81. The company has a market cap of $7.40 billion, a price-to-earnings ratio of 62.15 and a beta of 1.29.

STERIS PLC (NYSE:STE) last released its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. STERIS PLC had a net margin of 4.63% and a return on equity of 11.39%. The company had revenue of $608 million for the quarter, compared to analysts’ expectations of $597.66 million. During the same quarter last year, the business earned $0.79 EPS. The firm’s revenue was down 4.8% compared to the same quarter last year. Equities research analysts predict that STERIS PLC will post $4.06 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be paid a dividend of $0.31 per share. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a yield of 1.43%. STERIS PLC’s dividend payout ratio (DPR) is presently 88.57%.

ILLEGAL ACTIVITY WARNING: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/02/airain-ltd-decreases-position-in-steris-plc-ste.html.

A number of research firms recently weighed in on STE. Raymond James Financial, Inc. upped their target price on shares of STERIS PLC from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Zacks Investment Research lowered shares of STERIS PLC from a “buy” rating to a “hold” rating in a report on Tuesday, August 22nd. BidaskClub lowered shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Wellington Shields lowered shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $86.75.

In other news, VP Karen L. Burton sold 3,270 shares of STERIS PLC stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $85.70, for a total transaction of $280,239.00. Following the sale, the vice president now owns 11,807 shares in the company, valued at $1,011,859.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Mohsen Sohi sold 2,744 shares of STERIS PLC stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total transaction of $235,929.12. Following the sale, the director now owns 21,816 shares in the company, valued at approximately $1,875,739.68. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,554 shares of company stock worth $2,390,238. 2.55% of the stock is owned by company insiders.

About STERIS PLC

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Institutional Ownership by Quarter for STERIS PLC (NYSE:STE)

Receive News & Stock Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related stocks with our FREE daily email newsletter.